Literature DB >> 1532681

Characteristics and diffusion in the rabbit of a phage for Escherichia coli 0103. Attempts to use this phage for therapy.

A Reynaud1, L Cloastre, J Bernard, H Laveran, H W Ackermann, D Licois, B Joly.   

Abstract

A bacteriophage for Escherichia coli 0103 was isolated during a study on E. coli diarrhoea in intensive breeding units of rabbits. The phage had an isometric head and a short tail and resembled coliphage N4 (Podoviridae). It had a very narrow host range and seemed to be specific for serogroup 0103, suggesting that it might be used for preliminary identification of E. coli strains of this serogroup instead of the usual slide agglutination. In view of its possible use as a therapeutic phage, we investigated its dissemination in rabbit organs after oral administration. The phage persisted in the spleen for at least 12 days. However, in vivo studies showed that this phage and a mixture of more virulent phages for E. coli 0103 were ineffective in preventing disease in rabbits inoculated with an enteropathogenic strain of E. coli 0103.

Entities:  

Mesh:

Year:  1992        PMID: 1532681     DOI: 10.1016/0378-1135(92)90114-9

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  11 in total

Review 1.  Biological gene delivery vehicles: beyond viral vectors.

Authors:  Yiqi Seow; Matthew J Wood
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

Review 2.  Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.

Authors:  Krystyna Dąbrowska; Stephen T Abedon
Journal:  Microbiol Mol Biol Rev       Date:  2019-10-30       Impact factor: 11.056

3.  Ecological basis for rational phage therapy.

Authors:  A V Letarov; A K Golomidova; K K Tarasyan
Journal:  Acta Naturae       Date:  2010-04       Impact factor: 1.845

Review 4.  Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical review.

Authors:  Krystyna Dąbrowska
Journal:  Med Res Rev       Date:  2019-03-19       Impact factor: 12.944

Review 5.  Interactions between Bacteriophage, Bacteria, and the Mammalian Immune System.

Authors:  Jonas D Van Belleghem; Krystyna Dąbrowska; Mario Vaneechoutte; Jeremy J Barr; Paul L Bollyky
Journal:  Viruses       Date:  2018-12-25       Impact factor: 5.048

Review 6.  Prophage Activation in the Intestine: Insights Into Functions and Possible Applications.

Authors:  Jie Hu; Hao Ye; Shilan Wang; Junjun Wang; Dandan Han
Journal:  Front Microbiol       Date:  2021-12-13       Impact factor: 5.640

Review 7.  Clinical Pharmacology of Bacteriophage Therapy: A Focus on Multidrug-Resistant Pseudomonas aeruginosa Infections.

Authors:  Dana Holger; Razieh Kebriaei; Taylor Morrisette; Katherine Lev; Jose Alexander; Michael Rybak
Journal:  Antibiotics (Basel)       Date:  2021-05-11

8.  Metals Enhance the Killing of Bacteria by Bacteriophage in Human Blood.

Authors:  Li Ma; Sabrina I Green; Barbara W Trautner; Robert F Ramig; Anthony W Maresso
Journal:  Sci Rep       Date:  2018-02-02       Impact factor: 4.379

9.  Liver sinusoidal endothelial cells contribute to the uptake and degradation of entero bacterial viruses.

Authors:  Cristina I Øie; Deanna L Wolfson; Tanji Yasunori; Gianina Dumitriu; Karen K Sørensen; Peter A McCourt; Balpreet S Ahluwalia; Bård Smedsrød
Journal:  Sci Rep       Date:  2020-01-21       Impact factor: 4.379

10.  Gastrointestinal Dynamics of Non-Encapsulated and Microencapsulated Salmonella Bacteriophages in Broiler Production.

Authors:  Laura Lorenzo-Rebenaque; Danish J Malik; Pablo Catalá-Gregori; Clara Marin; Sandra Sevilla-Navarro
Journal:  Animals (Basel)       Date:  2022-01-08       Impact factor: 2.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.